Hydroxychloroquine
-
Sustained HCQ intake with PPE use helped prevent COVID-19 in healthcare workers: ICMR study
India | Jun 01, 2020, 07:30 AM ISTSustained intake of anti-malarial drug hyrdoxychloroquine (HCQ) along with appropriate use of personal protective equipment (PPE) led to a significant decline in the odds of healthcare workers getting infected with the coronavirus infection, a study has indicated.
-
Lancet issues correction on study that led WHO to pause HCQ trial
World | May 30, 2020, 03:53 PM ISTMedial journal The Lancet issued a correction on a large observational study that linked use of anti-malarial drug hydroxychloroquine with increased death risk in Covid-19 patients, after more than 100 scientists and medical professionals raised questions about integrity of data analysed in the study.
-
WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct: CSIR DG
News | May 30, 2020, 12:31 PM ISTCouncil of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early as possible.
-
Trump feeling 'absolutely great' after taking hydroxychloroquine: White House
World | May 29, 2020, 08:16 AM ISTUS President Donald Trump is "feeling absolutely great" after taking a two-week dose of antimalarial drug hydroxychloroquine and would take it again if he feels he is exposed to the coronavirus, a top White House official has said.
-
No major side-effects of HCQ found in Indian studies, usage to continue: ICMR
India | May 26, 2020, 06:11 PM ISTEven as the World Health Organisation (WHO) halted the hydroxychloroquine arm of its COVID-19 drug trials on Monday, the Indian Council of Medical Research (ICMR) today said that there were no major side-effects of the malaria drug in the studies in India.
-
Hydroxychloroquine-azithromycin combo may be potentially lethal: Study
Science | May 26, 2020, 01:41 PM ISTHydroxychloroquine and azithromycin, which have been proposed for treatment of COVID-19 patients, are a potentially lethal combination, and may have a serious impact on the cardiovascular system, according to a study.
-
WHO pauses trial of hydroxychloroquine in Covid-19 patients due to safety concerns
World | May 26, 2020, 06:46 AM ISTThe World Health Organisation (WHO) has suspended the trials of hydroxychloroquine as COVID-19 treatment citing safety concerns.
-
Trump says he has finished taking hydroxychloroquine as coronavirus therapy
India | May 25, 2020, 08:51 AM ISTTrump was addressing his disclosure last week that he was taking hydroxychloroquine and a zinc supplement. He said the regimen was meant to help prevent infection after two White House staffers tested positive for the coronavirus.
-
ICMR issues revised advisory on use of hydroxychloroquine
India | May 23, 2020, 07:51 AM ISTA revised government advisory on Friday recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-COVID-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection-related activities.
-
Hydroxychloroquine offering no benefit in COVID-19 patients: Lancet study
World | May 22, 2020, 07:14 PM ISTTreatment for COVID-19 with the antimalarial drug hydroxychloroquine, either with or without the antibiotic azithromycin, offers no benefit for COVID-19 patients, according to a large observational study.
-
US begins clinical trial of hydroxychloroquine, azithromycin
World | May 15, 2020, 11:08 AM ISTA clinical trial has begun in the US to evaluate whether the anti-malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent COVID-19 hospitalization and death, according to the National Institutes of Health (NIH).
-
India supplied paracetamol, hydroxychloroquine to over 120 countries in last 2 mths: Goyal
Business | May 14, 2020, 07:27 PM ISTIndia has supplied paracetamol and hydroxychloroquine to over 120 countries in the last two months while ensuring the domestic supply, as these two medicines are in huge demand due to COVID-19, Commerce and Industry Minister Piyush Goyal said on Thursday.
-
Hydroxychloroquine no wonder drug for treating COVID-19, can be fatal: Experts
World | May 07, 2020, 02:15 PM ISTCOVID-19, which broke out first in China’s Hubei province, has caused havoc across the world, claiming the lives of more than 2.6 lakh people and infected over 37 lakh.
-
Hydroxychloroquine linked to increased risk of cardiac arrhythmias: Study
Science | May 02, 2020, 12:19 PM ISTAt a time when the anti-malarial drug hydroxychloroquine (HCQ) is being touted as a 'wonder drug' to treat critical COVID-19 patients, a new US study has found evidence suggesting that patients who received hydroxychloroquine for COVID-19 were at an increased risk of electrical changes to the heart and cardiac arrhythmias.
-
Several US hospitals using hydroxychloroquine in treatment of COVID 19 patients: Report
World | May 02, 2020, 07:53 AM ISTSeveral hospitals in the United States continue to use malaria drug hydroxychloroquine in the treatment of COVID-19 positive patients, a media report said.
-
Hydroxychloroquine has 90% chance of helping COVID-19 patients: US doctors' body
Science | Apr 29, 2020, 09:01 PM ISTA team of US doctors has claimed that hydroxychloroquine, an anti-malarial drug termed potential "game-changer" for COVID-19 by President Donald Trump, has improved the survival and recovery odds for about 90 per cent of patients infected with the virus.
-
Hydroxychloroquine to be given to healthcare workers treating COVID-19 patients
India | Apr 29, 2020, 01:18 PM ISTHealth workers involved in the treatment of coronavirus patients will be given hydroxychloroquine (HCQ) tablets as a preventive medication, the Maharashtra government has said and issued guidelines on the use of the drug.
-
Home stay, Hydroxychloroquine and Aarogya Setu: New guidelines for mild symptoms of coronavirus
India | Apr 28, 2020, 12:06 PM ISTCoronavirus in India: According to a new set of guidelines issued on Monday, the patient should be clinically assigned as a very mild case or pre-symptomatic case by the treating medical officer.
-
Cardiac abnormalities in COVID-19 patients treated with hydroxychloroquine: Study
Science | Apr 26, 2020, 02:36 PM ISTPatients with COVID-19 who were on a regimen of the drugs hydroxychloroquine and azithromycin experienced cardiac abnormalities, according to a study which recommends the continuous monitoring of heart beat rhythms in infected people with underlying health conditions.
-
Hydroxychloroquine dangerous for heart ailments: FDA wans against side effects of malaria drug
World | Apr 25, 2020, 09:08 AM ISTFDA said as of now it has issued an emergency use authorisation to allow hydroxychloroquine and chloroquine products donated to the Strategic National Stockpile (SNS) to be distributed and used in limited circumstances, such as for certain hospitalised patients with COVID-19.